AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $69,000 | -63.9% | 1,137,920 | 0.0% | 0.02% | -63.5% |
| Q2 2022 | $191,000 | -64.3% | 1,137,920 | 0.0% | 0.05% | -59.4% |
| Q1 2022 | $535,000 | -17.6% | 1,137,920 | 0.0% | 0.13% | -20.5% |
| Q4 2021 | $649,000 | -42.2% | 1,137,920 | -3.0% | 0.16% | -80.1% |
| Q3 2021 | $1,123,000 | -42.7% | 1,173,200 | 0.0% | 0.81% | +45.3% |
| Q2 2021 | $1,959,000 | -1.2% | 1,173,200 | 0.0% | 0.56% | -25.9% |
| Q1 2021 | $1,983,000 | +6.3% | 1,173,200 | 0.0% | 0.75% | -34.2% |
| Q4 2020 | $1,865,000 | +66.1% | 1,173,200 | 0.0% | 1.14% | +41.2% |
| Q3 2020 | $1,123,000 | +50.3% | 1,173,200 | 0.0% | 0.81% | +32.1% |
| Q2 2020 | $747,000 | +53.4% | 1,173,200 | 0.0% | 0.61% | +24.3% |
| Q1 2020 | $487,000 | -28.8% | 1,173,200 | 0.0% | 0.49% | -21.6% |
| Q4 2019 | $684,000 | – | 1,173,200 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cypress Capital Management LLC (WY) | 234,225 | $132,000 | 0.18% |
| Noven Financial Group, Inc. | 123,772 | $70,000 | 0.04% |
| Harvest Investment Services, LLC | 109,443 | $60,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 559,489 | $314,000 | 0.03% |
| COURIER CAPITAL LLC | 354,973 | $199,000 | 0.03% |
| Valeo Financial Advisors, LLC | 330,000 | $185,000 | 0.02% |
| Transform Wealth, LLC | 205,481 | $115,000 | 0.02% |
| WEDBUSH SECURITIES INC | 326,793 | $184,000 | 0.02% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $31,000 | 0.02% |
| MONTAG A & ASSOCIATES INC | 230,000 | $129,000 | 0.01% |